Search results
Why pancreatic cancer symptoms are similar to other diseases
Rolling Out· 2 days agoPancreatic cancer is a daunting diagnosis that affects thousands of people worldwide every year. One...
Oneida County Health: hepatitis A risk for store customers who ate cooking demo food
Utica Observer-Dispatch via Yahoo News· 6 days agoSymptoms appear anywhere from 15 to 50 days after exposure, but 28 days is most common. Hepatitis A...
ALERT: Oneida County warns of Hepatitis A exposure at food demonstration
Rome Sentinel· 6 days agoThe Oneida County Health Department has learned of a Hepatitis A exposure during a recent food demonstration at Ace ...
Hepatitis A exposure from Ace Hardware in Rome
WSYR 9 Syracuse· 6 days agoROME, N.Y. (WSYR-TV) — The Oneida County Health Department announced on Tuesday, June 18, that a person at Ace Hardware in Rome who did a food...
12 Food Recalls That Will Always Haunt Walmart
Daily Meal via Yahoo News· 8 hours agoThere have been numerous recalls issued for food products sold at Walmart over the years. Here are the food recalls that will always haunt the retail...
Study suggests hepatitis E may be a sexually transmitted infection
Medical Xpress· 6 days agoResearchers have discovered that the hepatitis E virus is associated with sperm in pigs, which...
Free STI testing available every Tuesday at Norfolk Health Department Clinic
WAVY via Yahoo News· 8 hours agoTesting will be available every Tuesday on a walk-in basis. In addition to HIV testing, the Norfolk...
Sjogren's Syndrome
Health· 5 days agoIt may affect other parts of the body, causing additional symptoms. Researchers are still learning about the genetic and environmental factors that...
'I'm a doctor - by doing this one thing you could prevent five deadly diseases'
Daily Express· 3 days agoDr Sophia Khalique, a GP and expert in preventative healthcare, outlined key measures to take in...
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for...
Morningstar· 4 days agoGilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the company’s twice-yearly injectable HIV ...
